Form D · Biotechnology
IQUUM INC
Marlborough, MA · CIK 0001091299
Offering snapshot reported Dec 30, 2010 · SEC filing
- Reported sold
- $1M Offering amount: $5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 17, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 30, 2010 | Initial | $1,000,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-152753
Source: Form D, filed Dec 30, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lingjun Chen | Executive |
| Shuqui Chen | Director, Executive |
| Keith Greenfield | Director, Executive |
| Peter Rosenblum | Executive |
| Una Ryan | Director |
| Daniel Sutherby | Executive |
| David Taft | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
700 Nickerson Road
Marlborough, MA, 01752
Marlborough, MA, 01752